Martin G Schultz1, Andre La Gerche2, James E Sharman3. 1. Menzies Institute for Medical Research, University of Tasmania, Hobart, 7000, Australia. Martin.Schultz@utas.edu.au. 2. Baker Heart and Diabetes Institute, Melbourne, Australia. 3. Menzies Institute for Medical Research, University of Tasmania, Hobart, 7000, Australia.
Abstract
PURPOSE OF REVIEW: This review aimed to provide a clinical update on exercise blood pressure (BP) and its relationship to cardiovascular disease (CVD), outlining key determinants of abnormal exercise BP responses. We also highlight current evidence gaps that need addressing in order to optimise the relevance of exercise BP as clinical CVD risk factor. RECENT FINDINGS: Abnormal exercise BP manifests as either exercise hypotension (low BP response) or as exaggerated exercise BP (high BP response). Exercise hypotension is an established sign of existing and likely severe CVD, but exaggerated exercise BP also carries elevated CVD risk due to its association with sub-clinical hypertension. Although exaggerated exercise BP is related to heightened CVD risk at any exercise intensity, recent data suggest that the BP response to submaximal intensity exercise holds greater prognostic and clinical significance than BP achieved at peak/maximal intensity exercise. Cardiorespiratory fitness is a strong modifier of the exercise BP response, and should be taken into consideration when assessing the association with CVD. Both exercise hypotension and exaggerated exercise BP serve as markers that should prompt evaluation for potential underlying CVD. However, the clinical utility of these markers is currently inhibited by the lack of consensus informing the definitions and thresholds for abnormalities in exercise BP.
PURPOSE OF REVIEW: This review aimed to provide a clinical update on exercise blood pressure (BP) and its relationship to cardiovascular disease (CVD), outlining key determinants of abnormal exercise BP responses. We also highlight current evidence gaps that need addressing in order to optimise the relevance of exercise BP as clinical CVD risk factor. RECENT FINDINGS: Abnormal exercise BP manifests as either exercise hypotension (low BP response) or as exaggerated exercise BP (high BP response). Exercise hypotension is an established sign of existing and likely severe CVD, but exaggerated exercise BP also carries elevated CVD risk due to its association with sub-clinical hypertension. Although exaggerated exercise BP is related to heightened CVD risk at any exercise intensity, recent data suggest that the BP response to submaximal intensity exercise holds greater prognostic and clinical significance than BP achieved at peak/maximal intensity exercise. Cardiorespiratory fitness is a strong modifier of the exercise BP response, and should be taken into consideration when assessing the association with CVD. Both exercise hypotension and exaggerated exercise BP serve as markers that should prompt evaluation for potential underlying CVD. However, the clinical utility of these markers is currently inhibited by the lack of consensus informing the definitions and thresholds for abnormalities in exercise BP.
Authors: Jonathan Myers; Ross Arena; Barry Franklin; Ileana Pina; William E Kraus; Kyle McInnis; Gary J Balady Journal: Circulation Date: 2009-06-01 Impact factor: 29.690
Authors: Katharine D Currie; Ryan T Sless; Catherine F Notarius; Scott G Thomas; Jack M Goodman Journal: J Hypertens Date: 2017-08 Impact factor: 4.844
Authors: Peter F Kokkinos; Pittaras E Andreas; Emmanuel Coutoulakis; John A Colleran; Puneet Narayan; Charles O Dotson; Wassim Choucair; Colleen Farmer; Bo Fernhall Journal: J Cardiopulm Rehabil Date: 2002 May-Jun Impact factor: 2.081
Authors: Martin G Schultz; Petr Otahal; Verity J Cleland; Leigh Blizzard; Thomas H Marwick; James E Sharman Journal: Am J Hypertens Date: 2012-12-27 Impact factor: 2.689
Authors: Martin G Schultz; Dean S Picone; Sonja B Nikolic; Andrew D Williams; James E Sharman Journal: J Sci Med Sport Date: 2016-04-20 Impact factor: 4.319
Authors: Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood Journal: Eur Heart J Date: 2013-06-14 Impact factor: 29.983
Authors: Solomon Johnson; Victor R Gordeuk; Roberto Machado; J Simon R Gibbs; Mariana Hildesheim; Jane A Little; Gregory J Kato; Mark T Gladwin; Mehdi Nouraie Journal: Am J Hematol Date: 2021-10-20 Impact factor: 10.047
Authors: Joseph C Watso; Steven A Romero; Gilbert Moralez; Mu Huang; Matthew N Cramer; Elias Johnson; Craig G Crandall Journal: J Appl Physiol (1985) Date: 2022-08-11
Authors: Kirsten K Ness; Juan C Plana; Vijaya M Joshi; Russell V Luepker; Jean B Durand; Daniel M Green; Robyn E Partin; Aimee K Santucci; Rebecca M Howell; Deo Kumar Srivastava; Melissa M Hudson; Leslie L Robison; Gregory T Armstrong Journal: J Clin Oncol Date: 2019-10-17 Impact factor: 50.717